Julia Coronado is Chief Economist, North America for BNP Paribas' global market economics team. Prior to joining BNP Paribas, Julia was a Senior U.S. Economist at Barclays Capital in New York, where she helped formulate the forecast for the U.S. Economy and Fed policy. After receiving a Ph.D. in Economics from the University of Texas Julia worked as an Economist for the Federal Reserve Board of Governors in Washington D.C., working in Flow of Funds and Macroeconomic Analysis sections in the Division of Research and Statistics. She regularly briefed the Board and contributed to the FOMC forecasts, and she represented the Federal Reserve at meetings of the OECD’s Committee on Financial Markets. Julia has deep expertise in aging issues and worked as Director of Retirement Research at the think tank, Watson Wyatt Worldwide. She currently serves on the Board of Directors of the Pension Research Council at the Wharton School. Julia represents the firm’s economic views both to clients and the media and is a frequent commentator on economic issues in the financial press.
Posted In: U.S., Euro Eurozone, China, jobs report
The interest rate on 10 year government bonds is back up above 1.5 percent and Oil is down to $82 a barrel in New York trading. There are signs of a slowdown in Chinese manufacturing and continual uncertainty about the debt crisis in Europe.
Posted In: G8 summit, Obama, austerity
President Obama will be with world leaders in Chicago today after meetings at Camp David over the weekend. The takeaway from those meetings is that there should be more of a focus on growth rather than austerity as Europe grapples with another flare up in the debt crisis.
Posted In: Unemployment
After news that Sony is cutting 6 percent of its workforce and that the U.S. economy only added 120,000 jobs last month, the future doesn't look bright -- but a bigger picture shows it's all just part of a slow recovery.
Posted In: Mergers and Acquisitions, mergers, avon
The beauty and fragrance company Coty went public with its offer to buy rival Avon for about $10 billion -- that's an offer Avon so far has rejected. And Express Scripts and Medco -- two companies that process prescriptions at the drug store -- have gotten federal approval for their merger.
Posted In: China, economic growth
In China today, the government lowered the country's growth forecast for the year to 7.5 percent. That's the first target under 8 percent since 2005.